Busca un médico

Cyril Varghese, M.D., M.S.

  1. Critical Care Specialist

Publicaciones

  1. Varghese C, Johnson GB, Eiken PW, Edell ES, Specks U, Larson NB, Peikert T. A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis. Ann Am Thorac Soc. 2024 Nov; 21 (11):1533-1541
    View PubMed
  2. Pullins C, Varghese C, Koneru SS, Bracamonte JD. Radiographical bony lesions after discontinuation of immunosuppressant therapy: bone involvement in sarcoidosis. BMJ Case Rep. 2024 Apr 25; 17 (4)
    View PubMed
  3. Eggleston RH, Baqir M, Varghese C, Pennington KM, Bekele DI, Hartman TE, Ernste FC. Clinical Outcomes With and Without Plasma Exchange in the Treatment of Rapidly Progressive Interstitial Lung Disease Associated With Idiopathic Inflammatory Myopathy. J Clin Rheumatol. 2023 Apr 1; 29 (3):151-158 Epub 2022 Dec 07
    View PubMed
  4. Maldonado F, Varghese C, Rajagopalan S, Duan F, Balar AB, Lakhani DA, Antic SL, Massion PP, Johnson TF, Karwoski RA, Robb RA, Bartholmai BJ, Peikert T. Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules. Eur Respir J. 2021 Apr; 57 (4) Epub 2021 Apr 01
    View PubMed
  5. Khawaja A, Bartholmai BJ, Rajagopalan S, Karwoski RA, Varghese C, Maldonado F, Peikert T. Do we need to see to believe?-radiomics for lung nodule classification and lung cancer risk stratification. J Thorac Dis. 2020 Jun; 12 (6):3303-3316
    View PubMed
  6. Varghese C, Rajagopalan S, Karwoski RA, Bartholmai BJ, Maldonado F, Boland JM, Peikert T. Computed Tomography-Based Score Indicative of Lung Cancer Aggression (SILA) Predicts the Degree of Histologic Tissue Invasion and Patient Survival in Lung Adenocarcinoma Spectrum. J Thorac Oncol. 2019 Aug; 14 (8):1419-1429 Epub 2019 May 04
    View PubMed
  7. Gruwez H, Falter M, Sharain K, Varghese C, Click R. Incidental IVC tumor thrombus found on echocardiographic work-up for systolic murmur leading to new diagnosis of renal cell carcinoma. J Echocardiogr. 2018 Jun; 16 (2):93-94 Epub 2017 Nov 22
    View PubMed
  8. Kamboj AK, Shah S, Bhatia S, Andersen C, Varghese C. Disseminated Histoplasmosis: An Unusual Presentation of a Classic Midwest Infection. Am J Med 2018 Mar; 131 (3):e101-e102 Epub 2017 Oct 10
    View PubMed
  9. Kamboj AK, Cotter TG, Varghese C. Relapsing Polychondritis with Myelodysplastic Syndrome: A Case Report. Am J Med. 2017 Mar; 130 (3):e107-e108
    View PubMed
  10. Tabibian JH, Varghese C, LaRusso NF, O'Hara SP. The enteric microbiome in hepatobiliary health and disease. Liver Int. 2016 Apr; 36 (4):480-7 Epub 2015 Dec 12
    View PubMed
  11. Tabibian JH, Varghese C, O'Hara SP, LaRusso NF. Microbiome-Immune Interactions and Liver Disease. Clin Liver Dis (Hoboken). 2015 Apr; 5 (4):83-85 Epub 2015 May 07
    View PubMed
  12. Varghese C, Sharain K, Skalski J, Ramar K. Mycoplasma pneumonia-associated mucositis. BMJ Case Rep. 2014 Mar 13; 2014
    View PubMed
  13. Banerjee S, Das TS, Abu-Fadel MS, Dippel EJ, Shammas NW, Tran DL, Zankar A, Varghese C, Kelly KC, Weideman RA, Little BB, Reilly RF, Addo T, Brilakis ES. Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial. J Am Coll Cardiol. 2012 Oct 09; 60 (15):1352-9 Epub 2012 Sept 12
    View PubMed
  14. Banerjee S, Badhey N, Lichtenwalter C, Varghese C, Brilakis ES. Relationship of walking impairment and ankle-brachial index assessments with peripheral arterial translesional pressure gradients. J Invasive Cardiol. 2011 Sep; 23 (9):352-6
    View PubMed
  15. Banerjee S, Varghese C, Tran D, Hao X, Illum S, Brilakis ES.. Effect of preimplant endovascular debulking strategies on deployment of nitinol self-expanding stents in superficial femoral arteries. Cardiovascular Revascularization medicine.2011;12:(3):e2-e3.
  16. Banerjee S, Varghese C, Weideman R, Weideman M, Little BB. Proton pump inhibitors increase the risk of major adverse cardiovascular events in post-PCI patients who are on clopidogrel. European Heart Journal .2009;30:92.
  17. Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reilly RF, Brilakis ES. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol. 2008 Nov 01; 102 (9):1159-62 Epub 2008 Sept 11
    View PubMed
PST-20423678